PRESS RELEASES

March, 2017

Health Strategies Group Announces the Launch of Global Syndicated Market Research to its Portfolio

Now Available: KnowledgeEdge™ HTA Impact on Global Access provides insight on the influence of HTA on access, coverage, and reimbursement so you can anticipate the needs of HTA bodies in key geographies.

November, 2016

SIX COMPANIES MAINTAIN THE BEST RELATIONSHIPS WITH CLINICAL DECISION MAKERS

Gilead, Lilly, Novartis, Novartis Oncology, Novo Nordisk, and Sanofi have some of the best relationships with clinical decision makers at PBMs and health plans.

September, 2016

EIGHT BIOPHARMACEUTICAL COMPANIES BUILD BETTER RELATIONSHIPS WITH C-SUITE EXECUTIVES

AstraZeneca, Baxter, Boehringer Ingelheim, Johnson & Johnson HCS, Lilly, Merck, Novo Nordisk, and Pfizer—perform well across four cornerstones that drive company relationships with c-suite executives at hospitals and health systems.

September, 2016

HEALTH STRATEGIES GROUP LAUNCHES NEW RESEARCH MARKET ACCESS CUSTOMER RELATIONSHIPS

Health Strategies Group has announced the launch of its new research, Market Access Customer Relationships, focused on benchmarking your team’s performance against competitors on the competencies and attributes that lead to stronger customer relationships.

June, 2016

SIX COMPANIES EFFECTIVELY PARTNER WITH CONTRACTING DECISION MAKERS

AstraZeneca, BI, J&J HCS, Merck, Novartis, and Novo Nordisk achieve high marks in new report

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.